Compare Emerson Electric Co. (EMR) vs Lemonade Inc (LMND) Price & Performance

Emerson Electric (EMR) trades at $137.06, up 0.7% on the day, with a bearish technical signal but strong analyst support. Recent earnings have mostly beaten expectations, with Q2 2026 results pending. The company maintains solid profitability with a 13.35% net income margin and a consensus price target of $157.60, suggesting 15% upside. Cash flow trends show operational strength despite net outflows, and a dividend of $0.56 was recently declared.

EMR presents a mixed outlook: bullish fundamentals and analyst ratings contrast with near-term technical weakness. Investment appeal hinges on earnings execution and sector momentum, while risks include debt levels and market volatility. The stock's valuation at a P/E of 31.54 requires sustained growth to justify further gains.

Lemonade (LMND) trades at $64.675, down 7.79% over the past day, reflecting recent volatility. The stock shows a bullish technical signal with moving averages supporting upward momentum, while oscillators remain neutral. Fundamentally, revenue growth is robust, increasing from $257M in 2022 to $738M in 2025, but net losses persist, with a net income margin of -22.43% in 2025. Recent news highlights expansion into new states and reinsurance program improvements, driving investor interest despite profitability challenges.

The outlook for LMND is mixed; growth opportunities from AI-driven insurance expansion and state rollouts offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $69.60 price target, indicating limited near-term upside. Investors should weigh strong revenue trends against the path to profitability, with positive cash flow projected by 2026 being a key monitorable.